| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/13/2013 | CN102920892A Lung cancer treatment traditional Chinese medicine preparation and preparation method thereof |
| 02/13/2013 | CN102920891A Traditional Chinese medicine for non-surgical treatment of paranasal sinuses cancer patients |
| 02/13/2013 | CN102920868A Miao medicine for treating pancreatic diseases |
| 02/13/2013 | CN102920860A National medicinal composition for treating liver diseases |
| 02/13/2013 | CN102920855A Traditional Chinese medicine for treating cancers |
| 02/13/2013 | CN102920830A Method for effectively extracting polyphenol from Longan seed |
| 02/13/2013 | CN102920786A Method for preparing preparation capable of protecting liver, resisting tumors, reducing blood lipid and regulating immunity |
| 02/13/2013 | CN102920768A Cortex eucommiae capsule and preparation method thereof |
| 02/13/2013 | CN102920755A Method for preparing penthorum chinense pursh extract |
| 02/13/2013 | CN102920754A Moringa leaf extract and application of moringa leaf extract in aspect of effect enhancement and toxicity reduction for chemotherapy or radiotherapy of cancers |
| 02/13/2013 | CN102920746A Worm grass and Chinese blister beetle composition, enteric preparation, and application and preparation thereof |
| 02/13/2013 | CN102920730A Application of agaricus blazei murill polysaccharide extracts in lipid-lowering drug preparation |
| 02/13/2013 | CN102920709A Application of 2,3-dihydro-3-hydroxmethyl-6-methyl-[1,4]-benzoxazine in preparation of anti-breast cancer drug |
| 02/13/2013 | CN102920702A Dihydroartemisinin and Chinese blister beetle composition, enteric preparation and application and preparation thereof |
| 02/13/2013 | CN102920700A Application of 2-(4-hydroxybenzeneimido)-5-(3-methoxy-4-hydroxybenzylidene)-4-thiazolidone in preparation of antineoplastic drugs |
| 02/13/2013 | CN102920699A Application of 2-phenylimino-5-(4-dimethylamino benzylidene)-4-thiazolidone to preparation of anti-breast cancer medicament |
| 02/13/2013 | CN102920695A Benzofuran endothelin receptor antagonist and use |
| 02/13/2013 | CN102920694A Pharmaceutical composition with anti-tumor effect and preparation thereof |
| 02/13/2013 | CN102920688A Application of 4-hydroxy salicylanilide to preparation of medicament for preventing and treating hepatitis B |
| 02/13/2013 | CN102920687A Application of 1-(3,4,5-trihydroxy) phenyl-1-dinone in preparation of medicament for preventing or treating melanoma |
| 02/13/2013 | CN102920660A Novel liver cancer treatment preparation with physical and biological double-targeting effect |
| 02/13/2013 | CN102920657A 16-pregnadiene alcohol ketone submicron emulsion injection and preparation method thereof |
| 02/13/2013 | CN102920649A Drug-loading nano-micelles, and preparation method and application thereof |
| 02/13/2013 | CN102920635A Talcum powder capable of stopping bleeding, eliminate scars and resisting inflammation |
| 02/13/2013 | CN102382112B Compound for curing tumors, preparation method and application thereof |
| 02/13/2013 | CN102335252B Oral targeting preparation of compound three-root extract for resisting colorectal cancer and preparation method thereof |
| 02/13/2013 | CN102335139B Adriamycin sustained-release nano particles and preparation method thereof |
| 02/13/2013 | CN102225204B Anti-tumour pH sensitive slow release implant and preparation method thereof |
| 02/13/2013 | CN102218098B Pharmaceutical kit for treating breast cancer and new purpose thereof |
| 02/13/2013 | CN102002001B 2,2'-(1,4-phenylene) di(benzimidazole-5-carboxylic acid) and preparation method thereof |
| 02/13/2013 | CN101984963B Application of T-2 toxin to preparing drugs for treating pancreatic carcinoma |
| 02/13/2013 | CN101940569B Medicament composition containing sorafenib, artemisinin and artemisinin derivative and application thereof in preparing medicament for treating cancer |
| 02/13/2013 | CN101880308B New hopane-type triterpene and preparation method and application thereof |
| 02/13/2013 | CN101870726B Peptide - cisplatin conjugate and preparation method and application thereof |
| 02/13/2013 | CN101851294B Cell-penetrating peptide (Arg) 9 and lidamycin fusion protein (Arg) 9-LDP |
| 02/13/2013 | CN101837128B Medicament composition containing sorafenib, MEK inhibitors and EGFR tyrosine kinase inhibitors and application thereof |
| 02/13/2013 | CN101836989B Medicament composition containing tetrandrine, tetrandrine derivatives and histone deacetylase inhibitor and application thereof |
| 02/13/2013 | CN101775059B Novel glycyrrhetinic acid derivative, and preparation method and medicinal uses thereof |
| 02/13/2013 | CN101744767B Thermal sensitive liposome preparation containing camptothecin antineoplastic agents |
| 02/13/2013 | CN101693742B Anti-IGF-I receptor antibody |
| 02/13/2013 | CN101653608B Pharmaceutical composition containing hepatocyte growth factor receptor inhibitor and histone deacetylase inhibitor and application thereof |
| 02/13/2013 | CN101653607B Pharmaceutical composition containing hepatocyte growth factor receptor inhibitor and mitogen extracellular kinase inhibitor and application thereof |
| 02/13/2013 | CN101653606B Pharmaceutical composition containing protein kinase B inhibitor and epidermal growth factor recipient tyrosine kinase inhibitor and application thereof |
| 02/13/2013 | CN101624414B Nitrate medicament for inhibiting angiogenesis |
| 02/13/2013 | CN101537024B Method for preparing active anticancer fractions through conversion of total ginsenosides in panax plants by strain of fusarium sacchari |
| 02/13/2013 | CN101534852B Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 02/13/2013 | CN101460849B Diagnostic agent and therapeutic agent for pancreatic cancer |
| 02/13/2013 | CN101445469B Inhibitors of histone deacetylase |
| 02/13/2013 | CN101327201B Gossypol or liquid preparation of analogue thereof and preparation method and use thereof |
| 02/13/2013 | CN101219219B Complex containing vascellum chalone or fragment, preparation method and application thereof |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372971 Heterocyclic compounds and methods of use |
| 02/12/2013 | US8372968 RNA interference mediating small RNA molecules |
| 02/12/2013 | US8372831 Isoxazoline linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof |
| 02/12/2013 | US8372828 Therapeutic compositions |
| 02/12/2013 | US8372827 Therapeutic compositions |
| 02/12/2013 | US8372798 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability |
| 02/12/2013 | US8372449 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering pruified quinic acid and/or carboxy alkyl ester |
| 02/12/2013 | US8372448 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester |
| 02/12/2013 | US8372413 Mycobacterial disease, malaria, leishmaniasis, toxoplasmosis, schistosomiasis and clonorchiasis; antiallergens; asthma |
| 02/12/2013 | US8372406 Antitumoral and antiviral peptides |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | US8372393 Method of inducing a CTL response |
| 02/12/2013 | CA2701768C Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 02/12/2013 | CA2665707C Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 02/12/2013 | CA2596527C Igf-1r inhibitors |
| 02/12/2013 | CA2588401C 17,20(z)-dehydro vitamin d analogs and their uses |
| 02/12/2013 | CA2530281C Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders |
| 02/12/2013 | CA2529817C Novel antibacterial agents |
| 02/12/2013 | CA2487908C Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 02/12/2013 | CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors |
| 02/12/2013 | CA2477350C Novel crystalline forms of the anti-cancer compound zd1839 |
| 02/12/2013 | CA2468892C Vitamin d analogues |
| 02/12/2013 | CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 02/12/2013 | CA2382303C Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 02/12/2013 | CA2359650C Pharmaceutical preparations and methods for inhibiting tumors |
| 02/12/2013 | CA2345817C Novel methods for therapeutic vaccination |
| 02/12/2013 | CA2230144C Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 02/07/2013 | WO2013020062A1 Quinazoline compounds as serine/threonine kinase inhibitors |
| 02/07/2013 | WO2013020040A2 Radiated cancer cells as a vehicle for cancer nanotherapy |
| 02/07/2013 | WO2013020024A2 Maleimide compounds and methods of treatment |
| 02/07/2013 | WO2013019966A1 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | WO2013019938A1 Pyridazine derivatives as eaat2 activators |
| 02/07/2013 | WO2013019923A2 Methods for detecting progenitor cells and uses thereof |
| 02/07/2013 | WO2013019906A1 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors |
| 02/07/2013 | WO2013019648A1 Control of antibody responses to synthetic nanocarriers |
| 02/07/2013 | WO2013019548A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/07/2013 | WO2013019445A2 Anti-angiogenic peptides and uses thereof |
| 02/07/2013 | WO2013019222A1 Compositions and methods for treating myelodysplastic syndrome |
| 02/07/2013 | WO2013019221A1 Compositions and methods for treating myelodysplastic syndrome |
| 02/07/2013 | WO2013019093A2 Novel aniline derivatives and use thereof |
| 02/07/2013 | WO2013019079A2 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases |
| 02/07/2013 | WO2013019058A2 Pharmaceutical composition for inhibiting cancer recurrence or metastasis |
| 02/07/2013 | WO2013018929A1 Nitrogen-containing heterocyclic compound |
| 02/07/2013 | WO2013018894A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | WO2013018892A1 Drug composition for cancer treatment and/or prevention |
| 02/07/2013 | WO2013018891A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | WO2013018889A1 Cancer treatment and/or prevention drug composition |
| 02/07/2013 | WO2013018886A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |